Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial-Reference-Cited by-同舟云学术

Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial

Published:2019-03-11 Issue:10 Volume:44 Page:1812-1819
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Costi Sara,Soleimani Laili,Glasgow Andrew^ORCID,Brallier Jess,Spivack John,Schwartz Jaclyn^ORCID,Levitch Cara F.,Richards Samantha,Hoch Megan,Wade Elizabeth,Welch Alison,Collins Katherine A.,Feder Adriana,Iosifescu Dan V.,Charney Dennis S.,Murrough James W.

Funder

Doris Duke Charitable Foundation

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/s41386-019-0365-0.pdf

Reference30 articles.

1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547.

2. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.

3. Cipriani A, Geddes JR, Furukawa TA, Barbui C. Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Can J Psychiatry. 2007;52:553–62.